CEDIA DAU BENZODIAZEPINE ASSAY(MODIFICATION)

Enzyme Immunoassay, Benzodiazepine

MICROGENICS CORP.

The following data is part of a premarket notification filed by Microgenics Corp. with the FDA for Cedia Dau Benzodiazepine Assay(modification).

Pre-market Notification Details

Device IDK954626
510k NumberK954626
Device Name:CEDIA DAU BENZODIAZEPINE ASSAY(MODIFICATION)
ClassificationEnzyme Immunoassay, Benzodiazepine
Applicant MICROGENICS CORP. 2400 BISSO LN. Concord,  CA  94520
ContactPatricia Klimley
CorrespondentPatricia Klimley
MICROGENICS CORP. 2400 BISSO LN. Concord,  CA  94520
Product CodeJXM  
CFR Regulation Number862.3170 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received1995-10-03
Decision Date1995-11-27

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.